CTLA-4 Blockade for Melanoma: Past, Present and Future

被引：0
|
作者：
Wolchok, J. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71809-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [1] Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
    Van Allen, Eliezer M.
    Miao, Diana
    Schilling, Bastian
    Shukla, Sachet A.
    Blank, Christian
    Zimmer, Lisa
    Sucker, Antje
    Hillen, Uwe
    Foppen, Marnix H. Geukes
    Goldinger, Simone M.
    Utikal, Jochen
    Hassel, Jessica C.
    Weide, Benjamin
    Kaehler, Katharina C.
    Loquai, Carmen
    Mohr, Peter
    Gutzmer, Ralf
    Dummer, Reinhard
    Gabriel, Stacey
    Wu, Catherine J.
    Schadendorf, Dirk
    Garraway, Levi A.
    [J]. SCIENCE, 2015, 350 (6257) : 207 - 211
  • [2] Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
    Snyder, Alexandra
    Makarov, Vladimir
    Merghoub, Taha
    Yuan, Jianda
    Zaretsky, Jesse M.
    Desrichard, Alexis
    Walsh, Logan A.
    Postow, Michael A.
    Wong, Phillip
    Ho, Teresa S.
    Hollmann, Travis J.
    Bruggeman, Cameron
    Kannan, Kasthuri
    Li, Yanyun
    Elipenahli, Ceyhan
    Liu, Cailian
    Harbison, Christopher T.
    Wang, Lisu
    Ribas, Antoni
    Wolchok, Jedd D.
    Chan, Timothy A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (23): : 2189 - 2199
  • [3] Somatic Mutations and Immunotherapy Outcome with CTLA-4 Blockade in Melanoma
    Boussiotis, Vassiliki A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (23): : 2230 - 2232
  • [4] Melanoma reprogramming state correlates with response to CTLA-4 blockade in metastatic melanoma
    Karpinets, T.
    Calderone, T.
    Wani, K.
    Yu, X.
    Creasy, C.
    Haymaker, C.
    Forget, M.
    Nanda, V.
    Roszik, J.
    Wargo, J.
    Haydu, L.
    Song, X.
    Lazar, A.
    Gershenwald, J.
    Davies, M.
    Bernatchez, C.
    Zhang, J.
    Futreal, A.
    Woodman, S.
    [J]. HUMAN GENOMICS, 2016, 10
  • [5] Association of CTLA-4 Polymorphisms with Improved Overall Survival in Melanoma Patients Treated with CTLA-4 Blockade: A Pilot Study
    Queirolo, P.
    Morabito, A.
    Laurent, S.
    Lastraioli, S.
    Piccioli, P.
    Ascierto, P. A.
    Gentilcore, G.
    Serra, M.
    Marasco, A.
    Tornari, E.
    Dozin, B.
    Pistillo, M. P.
    [J]. CANCER INVESTIGATION, 2013, 31 (05) : 336 - 345
  • [6] Correction: Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
    Chan, Timothy A.
    Wolchok, Jedd D.
    Snyder, Alexandra
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (20): : 1984 - 1984
  • [7] CTLA-4 blockade: Autoimmunity as treatment
    Kapadia, D
    Fong, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) : 8926 - 8928
  • [8] CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations
    Camacho, Luis H.
    [J]. CANCER MEDICINE, 2015, 4 (05): : 661 - 672
  • [9] A predictive model to identify immunogenic neoepitopes in patients with melanoma treated with CTLA-4 blockade
    Chowell, Diego
    Krishna, Sri
    Snyder, Alexandra
    Vladimir, Makarov
    Chan, Timothy A.
    Anderson, Karen S.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [10] Murine malaria is exacerbated by CTLA-4 blockade
    Jacobs, T
    Graefe, SEB
    Niknafs, S
    Gaworski, I
    Fleischer, B
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (05): : 2323 - 2329
12345